A CLINICAL STUDY ON EKAKUSTHA(PSORIASIS) AND IT’S MANAGEMENT BY VAMANA KARMA AFTER TAKING OF PANCHAKOLA & SNEHAPANA

P. Mukherjee
{"title":"A CLINICAL STUDY ON EKAKUSTHA(PSORIASIS) AND IT’S MANAGEMENT BY VAMANA KARMA AFTER TAKING OF PANCHAKOLA & SNEHAPANA","authors":"P. Mukherjee","doi":"10.46344/jbino.2022.v11i03(b).03","DOIUrl":null,"url":null,"abstract":"Psoriasis is a non infectious chronic relapsing inflammatory skin diseases characterized by well defined dry scaly erythmatous patches & covered with adherent silvery white scales. Psoriasis can be correlated with “Ekakustha” in Ayurveda .Ekakustha is predominated with Vata & kafa dosa.The symptoms of Ekakustha -Aswedana {not perspire) ,mahavastu(extensive), masyasokolapama(looks like fish scale) and Arun barna(discolouration).In this clinical study 50 patents of psoriasis are selected according to inclusion & exclusion criteria. The total patients have been divided into three groups. Group A has been treated with “Panchakola powder’ (3 gm thrice before meal for 7 days); Group B patents have been treated by ‘Mahatiktak Ghrita”(as scheduled dose of snehapana up to samyak sneha lakshana is appeared 3-7 days);And Group C patients have been treated with Powder Panchakola +Mahatikta ghrita +Vamana karma (by Modan phala powder + Vacha pow +Saindhav lavana along with madhu & Yasthimadhu kwath),After administration of drugs & therapy the percentage of relief of Group A-Matsyasokolapama(55.83%), Rukhsata(53%), Arunattwa(50%), kandu (50%).In Group B patients after application of Panchakola + Mahatiktak Ghrita the percentage of relief Matsyasokolapama(42%), Rukhsata(58%), Arunattwa(42.5%) Kandu(40.82%)..And after administration of Panchakola powder +Mahatikta ghrita + Vamana in Group C patients the percentage of relief –Matsyasokolapama (67.78%) ,Rukshata(64.8%), Arunattwa(65.35%) kandu(72.01%).","PeriodicalId":228982,"journal":{"name":"Journal of Bio Innovation","volume":"16 ","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Bio Innovation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46344/jbino.2022.v11i03(b).03","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Psoriasis is a non infectious chronic relapsing inflammatory skin diseases characterized by well defined dry scaly erythmatous patches & covered with adherent silvery white scales. Psoriasis can be correlated with “Ekakustha” in Ayurveda .Ekakustha is predominated with Vata & kafa dosa.The symptoms of Ekakustha -Aswedana {not perspire) ,mahavastu(extensive), masyasokolapama(looks like fish scale) and Arun barna(discolouration).In this clinical study 50 patents of psoriasis are selected according to inclusion & exclusion criteria. The total patients have been divided into three groups. Group A has been treated with “Panchakola powder’ (3 gm thrice before meal for 7 days); Group B patents have been treated by ‘Mahatiktak Ghrita”(as scheduled dose of snehapana up to samyak sneha lakshana is appeared 3-7 days);And Group C patients have been treated with Powder Panchakola +Mahatikta ghrita +Vamana karma (by Modan phala powder + Vacha pow +Saindhav lavana along with madhu & Yasthimadhu kwath),After administration of drugs & therapy the percentage of relief of Group A-Matsyasokolapama(55.83%), Rukhsata(53%), Arunattwa(50%), kandu (50%).In Group B patients after application of Panchakola + Mahatiktak Ghrita the percentage of relief Matsyasokolapama(42%), Rukhsata(58%), Arunattwa(42.5%) Kandu(40.82%)..And after administration of Panchakola powder +Mahatikta ghrita + Vamana in Group C patients the percentage of relief –Matsyasokolapama (67.78%) ,Rukshata(64.8%), Arunattwa(65.35%) kandu(72.01%).
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
服用panchakola和snehapana后治疗银屑病的临床研究
牛皮癣是一种非传染性慢性复发性炎症性皮肤病,其特征是明确的干燥鳞状红斑斑块和覆盖着粘附的银白色鳞片。牛皮癣与阿育吠陀中的“Ekakustha”相关,Ekakustha以Vata和kafa dosa为主。Ekakustha的症状是aswedana(不出汗)、mahavastu(大量)、masyasokolapama(看起来像鱼鳞)和Arun barna(变色)。在本临床研究中,根据纳入和排除标准选择50例牛皮癣患者。所有患者被分为三组。A组患者给予“Panchakola散”(3 gm,餐前3次,连用7 d);B组患者用“maatiktak Ghrita”治疗(按照计划剂量服用snehapana至samyak sneha lakshana 3-7天);C组患者用Panchakola粉末+ maatikta Ghrita +Vamana karma(由Modan phala粉末+ Vacha pow +Saindhav lavana以及madhu和Yasthimadhu kwath)治疗,药物和治疗后,a组患者的缓解百分比为:matsyasokolapama (55.83%), Rukhsata(53%), Arunattwa(50%), kandu(50%)。B组患者应用Panchakola + maatiktak Ghrita后缓解率为:Matsyasokolapama(42%)、Rukhsata(58%)、Arunattwa(42.5%)、Kandu(40.82%)。C组患者经Panchakola散+ maatikta ghrita + Vamana治疗后缓解率为:matsyasokolapama(67.78%)、Rukshata(64.8%)、Arunattwa(65.35%)、kandu(72.01%)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
OVERVIEW OF ANEMIA AFTER SCOLIOSIS SURGERY IN THE INTENSIVE CARE UNIT (ICU) SOEHARSO ORTHOPEDIC HOSPITALINDONESIA EFFECT OF VERONIAAMYGDALINA ON THE ACTIVITIES OF HEPATIC ENZYMES IN WISTAR ALBINO RAT FED WITH CRUDE OIL CONTAMINATED DIET PATIENT SAFETY GOALS, AFRICA: DEVELOPMENT OF A CONTEXT FITTING TOOL FOR PATIENT SAFETY AND CARE QUALITY ASSESSMENT IN AFRICA USING THE DECIDE(HUMAN FACTORS) MODEL. IS THERE ANY RELATIONSHIP BETWEEN HUMAN BODY WEIGHT AND URINE NITRITE ALTERNATIVE THERAPIES FOR OXIDATIVE STRESS
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1